US HB5708 | 2023-2024 | 118th Congress
Status
Sponsorship: Bipartisan Bill
Status: Introduced on September 26 2023 - 25% progression, died in committee
Action: 2023-09-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 26 2023 - 25% progression, died in committee
Action: 2023-09-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to extend a priority review program to encourage treatments for agents that present national security threats.
Title
MCM PRV Reauthorization Act
Sponsors
| Rep. Brad Finstad [R-MN] | Rep. Dean Phillips [D-MN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-09-29 | House | Referred to the Subcommittee on Health. |
| 2023-09-26 | House | Referred to the House Committee on Energy and Commerce. |
| 2023-09-26 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/5708/all-info |
| Text | https://www.congress.gov/118/bills/hr5708/BILLS-118hr5708ih.pdf |
